Si-Mohamed A - Search Results

1

Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen.

Raymond S, Nicot F, Pallier C, Bellecave P, Maillard A, Trabaud MA, Morand-Joubert L, Rodallec A, Amiel C, Mourez T, Bocket L, Beby-Defaux A, Bouvier-Alias M, Lambert-Niclot S, Charpentier C, Malve B, Mirand A, Dina J, Le Guillou-Guillemette H, Marque-Juillet S, Signori-Schmuck A, Barin F, Si-Mohamed A, Avettand Fenoel V, Roussel C, Calvez V, Saune K, Marcelin AG, Rodriguez C, Descamps D, Izopet J; French National Agency for Research on AIDS and Viral Hepatitis (ANRS) AC11 Resistance Study Group. Raymond S, et al. Among authors: si mohamed a. Clin Infect Dis. 2018 May 2;66(10):1588-1594. doi: 10.1093/cid/cix1070. Clin Infect Dis. 2018. PMID: 29244143 Free PMC article.

2

Foscarnet salvage therapy efficacy is associated with the presence of thymidine-associated mutations (TAMs) in HIV-infected patients.

Charpentier C, Laureillard D, Sodqi M, Si-Mohamed A, Karmochkine M, Bélec L, Weiss L, Piketty C. Charpentier C, et al. J Clin Virol. 2008 Oct;43(2):212-5. doi: 10.1016/j.jcv.2008.07.001. Epub 2008 Aug 28. J Clin Virol. 2008. PMID: 18760662

3

High frequency of antiretroviral drug resistance among HIV-infected adults receiving first-line highly active antiretroviral therapy in N'Djamena, Chad.

Koyalta D, Charpentier C, Beassamda J, Rey E, Si-Mohamed A, Djemadji-Oudjeil N, Bélec L. Koyalta D, et al. Clin Infect Dis. 2009 Jul 1;49(1):155-9. doi: 10.1086/599611. Clin Infect Dis. 2009. PMID: 19480574

4

High frequency of integrase Q148R minority variants in HIV-infected patients naive of integrase inhibitors.

Charpentier C, Laureillard D, Piketty C, Tisserand P, Batisse D, Karmochkine M, Si-Mohamed A, Weiss L. Charpentier C, et al. AIDS. 2010 Mar 27;24(6):867-73. doi: 10.1097/QAD.0b013e3283367796. AIDS. 2010. PMID: 20160635

5

Dynamics of enfuvirtide resistance mutations in enfuvirtide-experienced patients remaining in virological failure under salvage therapy.

Charpentier C, Jenabian MA, Piketty C, Karmochkine M, Tisserand P, Laureillard D, Bélec L, Si-Mohamed A, Weiss L. Charpentier C, et al. Scand J Infect Dis. 2011 May;43(5):373-9. doi: 10.3109/00365548.2011.552520. Epub 2011 Feb 22. Scand J Infect Dis. 2011. PMID: 21341978

6

A cohort study of treatment-experienced HIV-1-infected patients treated with raltegravir: factors associated with virological response and mutations selected at failure.

Marcelin AG, Delaugerre C, Beaudoux C, Descamps D, Morand-Joubert L, Amiel C, Schneider V, Ferre V, Izopet J, Si-Mohamed A, Maillard A, Henquell C, Desbois D, Lazrek M, Signori-Schmuck A, Rogez S, Yerly S, Trabaud MA, Plantier JC, Fourati S, Houssaini A, Masquelier B, Calvez V, Flandre P; ANRS AC11 Resistance Group. Marcelin AG, et al. Among authors: si mohamed a. Int J Antimicrob Agents. 2013 Jul;42(1):42-7. doi: 10.1016/j.ijantimicag.2013.02.016. Epub 2013 Apr 4. Int J Antimicrob Agents. 2013. PMID: 23562640

7

Increased polymorphism in the HR-1 gp41 env gene encoding the enfuvirtide (T-20) target in HIV-1 variants harboring multiple antiretroviral drug resistance mutations in the pol gene.

Si-Mohamed A, Piketty C, Tisserand P, LeGoff J, Weiss L, Charpentier C, Kazatchkine MD, Bélec L. Si-Mohamed A, et al. J Acquir Immune Defic Syndr. 2007 Jan 1;44(1):1-5. doi: 10.1097/01.qai.0000243118.59906.f4. J Acquir Immune Defic Syndr. 2007. PMID: 17075396

8

Foscarnet as salvage therapy in HIV-2-infected patient with antiretroviral treatment failure.

Stegmann S, Manea ME, Charpentier C, Damond F, Karmochkine M, Laureillard D, Si-Mohamed A, Weiss L, Piketty C. Stegmann S, et al. J Clin Virol. 2010 Jan;47(1):79-81. doi: 10.1016/j.jcv.2009.11.008. Epub 2009 Dec 3. J Clin Virol. 2010. PMID: 19962343

9

Virological failure and HIV type 1 drug resistance profiles among patients followed-up in private sector, Douala, Cameroon.

Charpentier C, Talla F, Nguepi E, Si-Mohamed A, Bélec L. Charpentier C, et al. AIDS Res Hum Retroviruses. 2011 Feb;27(2):221-30. doi: 10.1089/aid.2010.0103. Epub 2010 Oct 26. AIDS Res Hum Retroviruses. 2011. PMID: 20977359

10

Lack of regression of anal squamous intraepithelial lesions despite immune restoration under cART.

Piketty C, Cochand-Priollet B, Lanoy E, Si-Mohamed A, Trabelsi S, Tubiana R, Girard PM, Weiss L, Costagliola D; Valparaiso Study Group. Piketty C, et al. Among authors: si mohamed a. AIDS. 2013 Jan 28;27(3):401-6. doi: 10.1097/QAD.0b013e32835ad2cb. AIDS. 2013. PMID: 23079803

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters